风湿性疾病患者SARS-CoV-2感染的流行病学特征和结局:来自阿根廷sars - covid登记处的第一份报告

C. Isnardi, G. Gomez, R. Quintana, Karen Roberts, G. Berbotto, R. Báez, F. Maldonado, V. C. Castro Coello, C. Graf, G. Pons-Estel
{"title":"风湿性疾病患者SARS-CoV-2感染的流行病学特征和结局:来自阿根廷sars - covid登记处的第一份报告","authors":"C. Isnardi, G. Gomez, R. Quintana, Karen Roberts, G. Berbotto, R. Báez, F. Maldonado, V. C. Castro Coello, C. Graf, G. Pons-Estel","doi":"10.47196/rar.v32i1.364","DOIUrl":null,"url":null,"abstract":"In order to assess the impact of SARS-CoV-2 infection in patients with rheumatic diseases, the Argentine Society of Rheumatology has developed the National Registry of Patients with Rheumatic Diseases and COVID-19 (SAR-COVID). The aim of this study was to evaluate the sociodemographic and clinical characteristics of patients with rheumatic diseases and SARS-CoV-2 infection included in the SAR-COVID registry and to describe the complications and outcomes of COVID-19 in this population.\nMethods: SAR-COVID is a national, multicenter and observational registry, in which patients ≥18 years of age, with a diagnosis of a rheumatic disease who had SARS-CoV-2 infection are consecutively included. Sociodemographic data, comorbidities, underlying rheumatic disease and treatment, clinical characteristics, complications, laboratory and treatment of the SARS-CoV-2 infection were recorded.\nResults: a total of 525 patients were included, with a mean age of 51.3 years (SD 15.2). The most frequent rheumatic diseases were rheumatoid arthritis (40.4%), systemic lupus erythematous (14.9%) and spondyloarthritis (8.2%). At the time of the infection, 72.9% were receiving immunosuppressive or immunomodulatory treatment and 36.9% glucocorticoids. Most of the patients were diagnosed using RT-PCR (95%), at outpatient consultation (39.4%), at the emergency room (32.2%) or during hospitalization (14.7%). Symptoms were present in 96% of the patients, the most frequent being fever (56.2%), cough (46.7%) and headache (39.2%). During infection, 35.1% were hospitalized, 11.6% were admitted to the ICU and 6.9% died due to COVID-19. Most of them (75.1%) recovered completely.\nConclusions: in this first report of the SAR-COVID registry we found a wide distribution of\nrheumatic diseases. Most of the patients had a good evolution of the infection, however 7% died as a result of it, comparable to other Latin American registries with similar populations.","PeriodicalId":249076,"journal":{"name":"Revista Argentina de Reumatología","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiological characteristics and outcomes of SARS-CoV-2 infection in patients with rheumatic diseases: first report from the Argentine SAR-COVID registry\",\"authors\":\"C. Isnardi, G. Gomez, R. Quintana, Karen Roberts, G. Berbotto, R. Báez, F. Maldonado, V. C. Castro Coello, C. Graf, G. Pons-Estel\",\"doi\":\"10.47196/rar.v32i1.364\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In order to assess the impact of SARS-CoV-2 infection in patients with rheumatic diseases, the Argentine Society of Rheumatology has developed the National Registry of Patients with Rheumatic Diseases and COVID-19 (SAR-COVID). The aim of this study was to evaluate the sociodemographic and clinical characteristics of patients with rheumatic diseases and SARS-CoV-2 infection included in the SAR-COVID registry and to describe the complications and outcomes of COVID-19 in this population.\\nMethods: SAR-COVID is a national, multicenter and observational registry, in which patients ≥18 years of age, with a diagnosis of a rheumatic disease who had SARS-CoV-2 infection are consecutively included. Sociodemographic data, comorbidities, underlying rheumatic disease and treatment, clinical characteristics, complications, laboratory and treatment of the SARS-CoV-2 infection were recorded.\\nResults: a total of 525 patients were included, with a mean age of 51.3 years (SD 15.2). The most frequent rheumatic diseases were rheumatoid arthritis (40.4%), systemic lupus erythematous (14.9%) and spondyloarthritis (8.2%). At the time of the infection, 72.9% were receiving immunosuppressive or immunomodulatory treatment and 36.9% glucocorticoids. Most of the patients were diagnosed using RT-PCR (95%), at outpatient consultation (39.4%), at the emergency room (32.2%) or during hospitalization (14.7%). Symptoms were present in 96% of the patients, the most frequent being fever (56.2%), cough (46.7%) and headache (39.2%). During infection, 35.1% were hospitalized, 11.6% were admitted to the ICU and 6.9% died due to COVID-19. Most of them (75.1%) recovered completely.\\nConclusions: in this first report of the SAR-COVID registry we found a wide distribution of\\nrheumatic diseases. Most of the patients had a good evolution of the infection, however 7% died as a result of it, comparable to other Latin American registries with similar populations.\",\"PeriodicalId\":249076,\"journal\":{\"name\":\"Revista Argentina de Reumatología\",\"volume\":\"28 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Argentina de Reumatología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47196/rar.v32i1.364\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Argentina de Reumatología","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47196/rar.v32i1.364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

为了评估SARS-CoV-2感染对风湿病患者的影响,阿根廷风湿病学会制定了国家风湿病和COVID-19患者登记处(SAR-COVID)。本研究的目的是评估纳入sars - covid登记的风湿病和SARS-CoV-2感染患者的社会人口学和临床特征,并描述该人群中COVID-19的并发症和结局。方法:sars - covid是一项全国性、多中心、观察性登记,连续纳入年龄≥18岁、诊断为风湿病且感染SARS-CoV-2的患者。记录SARS-CoV-2感染的社会人口统计资料、合并症、潜在的风湿病和治疗、临床特征、并发症、实验室和治疗。结果:共纳入525例患者,平均年龄51.3岁(SD 15.2)。最常见的风湿病是类风湿关节炎(40.4%)、系统性红斑狼疮(14.9%)和脊椎关节炎(8.2%)。感染时接受免疫抑制或免疫调节治疗的占72.9%,接受糖皮质激素治疗的占36.9%。大多数患者是通过RT-PCR(95%)、门诊(39.4%)、急诊室(32.2%)或住院(14.7%)诊断的。96%的患者出现症状,最常见的是发热(56.2%)、咳嗽(46.7%)和头痛(39.2%)。感染期间住院35.1%,进ICU 11.6%,死亡6.9%。大部分患者(75.1%)完全康复。结论:在sars - covid登记的第一份报告中,我们发现风湿病分布广泛。大多数患者有良好的感染演变,但7%的患者因此死亡,与具有类似人群的其他拉丁美洲登记处相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epidemiological characteristics and outcomes of SARS-CoV-2 infection in patients with rheumatic diseases: first report from the Argentine SAR-COVID registry
In order to assess the impact of SARS-CoV-2 infection in patients with rheumatic diseases, the Argentine Society of Rheumatology has developed the National Registry of Patients with Rheumatic Diseases and COVID-19 (SAR-COVID). The aim of this study was to evaluate the sociodemographic and clinical characteristics of patients with rheumatic diseases and SARS-CoV-2 infection included in the SAR-COVID registry and to describe the complications and outcomes of COVID-19 in this population. Methods: SAR-COVID is a national, multicenter and observational registry, in which patients ≥18 years of age, with a diagnosis of a rheumatic disease who had SARS-CoV-2 infection are consecutively included. Sociodemographic data, comorbidities, underlying rheumatic disease and treatment, clinical characteristics, complications, laboratory and treatment of the SARS-CoV-2 infection were recorded. Results: a total of 525 patients were included, with a mean age of 51.3 years (SD 15.2). The most frequent rheumatic diseases were rheumatoid arthritis (40.4%), systemic lupus erythematous (14.9%) and spondyloarthritis (8.2%). At the time of the infection, 72.9% were receiving immunosuppressive or immunomodulatory treatment and 36.9% glucocorticoids. Most of the patients were diagnosed using RT-PCR (95%), at outpatient consultation (39.4%), at the emergency room (32.2%) or during hospitalization (14.7%). Symptoms were present in 96% of the patients, the most frequent being fever (56.2%), cough (46.7%) and headache (39.2%). During infection, 35.1% were hospitalized, 11.6% were admitted to the ICU and 6.9% died due to COVID-19. Most of them (75.1%) recovered completely. Conclusions: in this first report of the SAR-COVID registry we found a wide distribution of rheumatic diseases. Most of the patients had a good evolution of the infection, however 7% died as a result of it, comparable to other Latin American registries with similar populations.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信